Single Dose Therapeutics is dedicated to improving mental health care by developing short-regimen neuroplastogens that enhance psychological resilience. Our mission is to advance these innovative pharmacotherapies through rigorous research and clinical trials, ensuring they become accessible and effective treatment options for psychiatric conditions with unmet needs and those that currently require chronic treatment. We aim to provide innovative therapeutic options that foster durable mental well-being.
Company Details
- Employees
- 1
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://www.singledose.one
- Keywords
- Corvallis.
Single Dose Therapeutics Questions
Single Dose Therapeutics's website is https://www.singledose.one
Single Dose Therapeutics's LinkedIn profile is https://www.linkedin.com/company/singledose
Single Dose Therapeutics has
1 employees.
View email and phone details for 1
employees at Single Dose Therapeutics.
Single Dose Therapeutics's industry is
Biotechnology Research
Single Dose Therapeutics's top competitors are
Healthtech Content,
Gilead Sciences,
Sievestack,
Manitou Group,
Qubit Capital.
Single Dose Therapeutics's categories are Biotechnology Research
